AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+48.83%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.88B
AUM Growth
+$3.88B
(+32%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
74.76%
Holding
127
New
34
Increased
29
Reduced
17
Closed
18
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$65.1M |
| 2 |
Arrowhead Research
ARWR
|
$57.4M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$29.5M |
| 4 |
Vera Therapeutics
VERA
|
$21.8M |
| 5 |
Solid Biosciences
SLDB
|
$21.2M |
Top Sells
| 1 |
CAVA Group
CAVA
|
$385M |
| 2 |
Cytokinetics
CYTK
|
$49.6M |
| 3 |
argenx
ARGX
|
$44.3M |
| 4 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$14.8M |
| 5 |
Natera
NTRA
|
$12.5M |
Sector Composition
| 1 | Healthcare | 50.84% |
| 2 | Consumer Discretionary | 48.42% |
| 3 | Technology | 0.53% |
| 4 | Real Estate | 0.1% |
| 5 | Financials | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tourmaline Bio
TRML
$601M
| $7.2M | 0.18% | 314,496 +223,070 | +244% | +$5.11M |
|
52
Applied Therapeutics
APLT
$71M
| $6.86M | 0.17% | +1,009,500 | New | +$6.86M |
|
53
Pinduoduo
PDD
$171B
| $6.57M | 0.17% | 56,500 +24,000 | +74% | +$2.79M |
|
54
Structure Therapeutics
GPCR
$1.11B
| $6.51M | 0.17% | 151,780 +65,180 | +75% | +$2.79M |
|
|
VIGL
55
DELISTED
Vigil Neuroscience
VIGL
| $6.18M | 0.16% | 1,811,191 | – | – |
|
56
Axsome Therapeutics
AXSM
$6.05B
| $6.13M | 0.16% | +76,837 | New | +$6.13M |
|
57
Cartesian Therapeutics
RNAC
$261M
| $5.94M | 0.15% | 9,136,635 | – | – |
|
58
Alto Neuroscience
ANRO
$99.6M
| $5.37M | 0.14% | +350,000 | New | +$5.37M |
|
59
Black Diamond Therapeutics
BDTX
$157M
| $5.31M | 0.14% | 1,046,517 -1,000,000 | -49% | -$5.07M |
|
60
Regenxbio
RGNX
$451M
| $5.27M | 0.13% | +250,000 | New | +$5.27M |
|
|
KLRS
61
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $4.98M | 0.13% | 6,597,167 | – | – |
|
62
Kyverna Therapeutics
KYTX
$160M
| $4.97M | 0.13% | +200,000 | New | +$4.97M |
|
63
Foghorn Therapeutics
FHTX
$286M
| $4.84M | 0.12% | 720,720 | – | – |
|
|
OMGA
64
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $4.83M | 0.12% | 1,323,530 | – | – |
|
65
TSMC
TSM
$1.2T
| $4.35M | 0.11% | 32,000 -35,999 | -53% | -$4.9M |
|
66
Geron
GERN
$893M
| $4.23M | 0.11% | +1,281,194 | New | +$4.23M |
|
67
Stoke Therapeutics
STOK
$1.08B
| $4.05M | 0.1% | +300,000 | New | +$4.05M |
|
|
HOOK
68
DELISTED
HOOKIPA Pharma
HOOK
| $4.03M | 0.1% | 5,666,410 | – | – |
|
69
Sagimet Biosciences
SGMT
$244M
| $3.93M | 0.1% | 724,771 -200,000 | -22% | -$1.08M |
|
70
KE Holdings
BEKE
$20.8B
| $3.78M | 0.1% | 275,000 +25,000 | +10% | +$343K |
|
71
Repare Therapeutics
RPTX
$71.7M
| $3.3M | 0.08% | 700,000 | – | – |
|
72
Metagenomi
MGX
$65.3M
| $3.17M | 0.08% | +300,000 | New | +$3.17M |
|
73
PepGen
PEPG
$38M
| $2.94M | 0.07% | +200,000 | New | +$2.94M |
|
|
ADAG
74
Adagene
ADAG
$100M
| $2.86M | 0.07% | 1,020,000 +20,000 | +2% | +$56K |
|
|
GRTS
75
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.65M | 0.07% | +1,030,952 | New | +$2.65M |
|